Crinetics Pharmaceuticals (CRNX) Shares Issued (2017 - 2026)

Crinetics Pharmaceuticals has reported Shares Issued for 10 years, with the latest figure at $380.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $380.5 million; the trailing twelve-month figure through Mar 2026 stood at $371.9 million (down 37.38% YoY), and the FY2024 full-year result was $985.0 million, up 166.54% from the prior year.
• Shares Issued for Q1 2026 stood at $380.5 million, up from -$14.6 million in the prior quarter.
• The five-year high for Shares Issued was $543.5 million in Q4 2024, with the low at -$14.6 million in Q4 2025.
• Average Shares Issued over 5 years is $104.5 million, with a median of $3.0 million recorded in 2025.
• Year-over-year, Shares Issued surged 4235.71% in 2022 and sank 102.68% in 2025.
• Tracing CRNX's Shares Issued over 5 years: stood at $112.6 million in 2022, then soared by 227.1% to $368.4 million in 2023, then soared by 47.52% to $543.5 million in 2024, then slumped by 102.68% to -$14.6 million in 2025, then jumped by 2710.55% to $380.5 million in 2026.
• The last three Shares Issued figures came in at $380.5 million (Q1 2026), -$14.6 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.

Peer Comparison